BioPharm International - November 2023

BioPharm International - November 2023

Issue link: https://www.e-digitaleditions.com/i/1511466

Contents of this Issue

Navigation

Page 2 of 28

Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 29 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics offering spans discovery to clinic and fill-finish services across monoclonal antibodies, recombinant proteins and mRNA therapeutics. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics. © 2023 Curia Global, Inc. All rights reserved. to cure From curiosity To learn more visit us at curiaglobal.com/biologics SM

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - November 2023 - BioPharm International - November 2023